Vivex® Biologics, Inc. Appoints Industry Veteran Jon E. Block, Ph.D., as Chief Clinical Officer [Yahoo! Finance]
Medtronic plc. Ordinary Shares (MDT)
Last medtronic plc. ordinary shares earnings: 2/18 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investorrelations.medtronic.com
Company Research
Source: Yahoo! Finance
MIAMI, June 10, 2025 (GLOBE NEWSWIRE) -- Vivex Biologics, Inc. , a leader in developing and delivering innovative allografts, today announced the appointment of Jon E. Block, Ph.D., an industry luminary with more than 40 years of leadership experience in clinical research, medical affairs, and regulatory strategy, as the company's Chief Clinical Officer. In this role, Dr. Block will spearhead Vivex's clinical development initiatives, particularly the completion of Vivex's Ascend and Restore randomized clinical trials for VIA Disc NP, Vivex's procedure for supplementing discs in patients with symptomatic disc degeneration. Dr. Block will also oversee the design and execution of Vivex's clinical trials for its orthofusion and wound allografts and drive strategic alignment between clinical, regulatory, and commercial teams to support the company's growing portfolio of innovative allograft products. “We are delighted to welcome Dr. Block to Vivex in this leadership role as we look to
Show less
Read more
Impact Snapshot
Event Time:
MDT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MDT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MDT alerts
High impacting Medtronic plc. Ordinary Shares news events
Weekly update
A roundup of the hottest topics
MDT
News
- Stifel Maintains Hold on Medtronic (MDT) After FDA Approves HUGO System [Yahoo! Finance]Yahoo! Finance
- Medtronic: A Defensive Gem For Uncertain Times [Seeking Alpha]Seeking Alpha
- Medtronic announces filing of IPO registration statement for Diabetes business, MiniMedPR Newswire
- Medtronic (NYSE:MDT) had its price target lowered by analysts at Truist Financial Corporation from $110.00 to $107.00. They now have a "hold" rating on the stock.MarketBeat
- Medtronic (NYSE:MDT) was given a new $103.00 price target on by analysts at Robert W. Baird.MarketBeat
MDT
Earnings
- 11/18/25 - Beat
MDT
Sec Filings
- 12/17/25 - Form 4
- 12/17/25 - Form 4
- 12/17/25 - Form 4
- MDT's page on the SEC website